REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

Sheba Study Debunks Link Between COVID-19 Vaccine and Infertility

debunking covid-19 vaccine and infertility
A new study from Sheba’s Gynecology and Maternity Center found no change in hormone levels among recipients of the Pfizer-BioNTech vaccine.

According to a new Sheba Medical Center study, COVID-19 vaccines have no notable impact on fertility in women. The study assessed levels of an ovarian reserve indicator called anti-Müllerian hormone (AMH) and found no notable difference after the vaccine was administered.

During the study, led by Prof. Jaron Rabinovici, Deputy Director of Sheba’s Gynecology and Maternity Center, 129 participants were administered both doses of the Pfizer-BioNTech COVID-19 vaccine. Hormone levels were measured three months before the first dose, as well as three months after, and compared. Participants were studied both overall and by age group.

Sheba researchers will continue to monitor participants to check for any long-term effects, and an additional follow-up study focusing on girls between the ages of 12 and 18 is planned.

Since COVID-19 vaccines first became available, some have expressed concerns about side effects. However, experts have long contradicted these claims, and Sheba’s latest study supports this conclusion. In fact, studies have indicated that COVID-19 infections could have a negative impact on fertility, underscoring the importance of receiving the vaccine.

Related

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More
Hemophilia research
News Sep 05.

New Sheba Study Indicates: Novel Treatment Sharply Reduces Bleed Rates Among Hemophilia Patients

Results indicate that a monthly treatment with Fitusiran significantly reduces bleed rates among both hemophilia A and B patients.
Read More